홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TBPH
#2574
Theravance Biopharma, Inc.
16.580
0
USD
-0.12%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-0.12%
월간 변동
+18.94%
6달 변화
+15.54%
년간 변동율
+15.54%
이전 종가
16.600
0
Open
16.540
0
Bid
Ask
Low
16.540
0
High
16.580
0
양
41
마켓
주식
헬스케어
TBPH
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
49.47 M
50 M
50.36 M
50.67 M
51.49 M
—
Valuation ratios
Enterprise value
427.72 M
335.9 M
273.56 M
565.04 M
795.63 M
1.97 B
Price to earnings ratio
-8.18
-7.57
45.96
25.61
9.08
73.09
Price to sales ratio
7.14
6.71
7.1
9.15
8.97
31.93
Price to cash flow ratio
-39.85
13.72
2.28
3.03
4.04
23.06
Price to book ratio
2.62
0.61
0.73
0.92
3.25
5.5
EBITDA 비율에 대한 기업 가치
-9.8
-6.93
-7.7
-18.13
-1 671.48
-1 704.24
Profitability ratios
Return on assets %
-0.04
-0.04
0.13
0.01
0.13
0.22
Return on equity %
-0.09
-0.08
0.24
0.02
0.21
0.38
Return on invested capital %
-25.43
-24.24
-5.71
41.13
58.52
69.7
Gross margin %
100
100
100
100
100
400
Operating margin %
-49.06
-93.8
-10.4
-32.29
43.61
-92.89
EBITDA margin %
-46.81
-91.12
-8.84
-30.27
44.48
-85.75
Net margin %
-82.79
-88.24
209.33
18.08
132.98
272.15
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.02
4.77
6.7
9.48
10.93
31.88
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.05
0.04
0.07
0.05
0.1
0.26
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.02
0.87
4.1
-0.13
-0.12
4.72
EBIT per share
-0.19
-0.29
-0.05
-0.12
0.39
-0.08
EBITDA per share
-0.18
-0.28
-0.05
-0.12
0.4
-0.05
Total debt per share
—
—
—
—
—
—
Cash per share
1.81
2.63
6.68
6.35
6.12
21.79
Net current asset value per share
3.3
3.02
7.22
6.83
8.12
25.2
Tangible book value per share
3.59
3.34
4.43
4.48
5.76
18.02
Working capital per share
2.64
2.39
6.14
6.11
7.38
22.03
Book value per share
3.59
3.34
4.43
4.48
5.76
18.02
뉴스
Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock
Theravance's Q4 Earnings and Revenues Miss Estimates
Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)
Down 30.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)
오펜하이머, 테라반스 바이오파마 투자의견 강등
Oppenheimer downgrades Theravance Biopharma stock rating on Phase 3 miss
TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
B.라일리, 임상 실패로 Theravance Biopharma 등급 하향
B.Riley cuts Theravance Biopharma stock rating on trial failure
Micron and MongoDB among market cap stock movers on Tuesday